The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse

Abstract Coronavirus disease 2019 (COVID-19), caused by the 2019 novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently responsible for a global pandemic. To date, only remdesivir and dexamethasone have demonstrated a positive response in a prospective, randomized trial for...

Full description

Bibliographic Details
Main Authors: Taylor Morrisette, Thomas P. Lodise, Marc H. Scheetz, Srijib Goswami, Jason M. Pogue, Michael J. Rybak
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-08-01
Series:Infectious Diseases and Therapy
Subjects:
COVID-19
Hydroxychloroquine
Pharmacodynamics
Pharmacokinetics
Online Access:https://doi.org/10.1007/s40121-020-00325-2

Internet

https://doi.org/10.1007/s40121-020-00325-2

Similar Items